Multiple mechanisms may lead to Akt activation in human cancers, among which the most frequent genetic alternations include loss of the tumor suppressor phosphatase and tensin homolog10,11 and mutational activation of the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K)12,13. Here, AKT1 is linked to cancer.